Abstract:Objective To study the direct anti-tumor effects of the Mycobacterium bovis bacillus Calmette-Guerin(BCG)-activated dendritic cell(DC) vaccine in vitro and in vivo. Methods DCs were harvested from bone marrow of C57BL/6 mice and cultured with BCG to stimulate maturation.Activated DCs were evaluated by flow cytometry(FCM).Activated DCs were co-cultured with the pancreatic tumor cell line,Panc02,and cytotoxic response was measured by the CCK-8 kit.The frequency of activated DCs expressing tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) was measured by FCM,and TRAIL mRNA levels were detected by real-time PCR.C57BL/6 mice were implanted with Panc02 tumor cells by subcutaneous inoculation,and on the seventh day were randomly divided into three groups: untreated control,injected with saline;DC vaccine-treated by intratumoral injection;DC vaccine-treated by subcutaneous injection.For all mice,injections were delivered twice with a one-week interval.On day 15 after the second injection,all the mice were sacrificed to evaluate tumor weights. Results In vitro,the BCG-activated DCs showed obvious typical dendritic structures and the phenotypic increase in CD86 marker expression.Surface expression of TRAIL was also increased on BCG-activated DCs.Activated DCs suppressed the growth of Panc02 tumor cells in culture,and this response was partially alleviated by anti-TRAIL antibody.In vivo,BCG-activated DCs decreased the Panc02-derived tumor weights(vs untreated group),and intratumoral injection produced lower tumor weights than subcutaneous injection. Conclusion The efficacy of DC-based vaccines for pancreatic cancer may be improved by first activating the DCs with BCG.BCG-activated DCs can directly suppress the growth of Panc02 tumor cells in vitro through TRAIL.Intratumoral injection of the BCG-activated DC vaccine has a more robust anti-tumor effect than the subcutaneous route.

Antitumor efficacy of specific cytotoxic T lymphocytes activiated by dendritic cells to gastric cancer ex vivo

In vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigen

Induction of tumor-specific cytotoxic T lymphocytes in vitro by dendritic cells pulsed with different glioma antigens

Study on Tumor-Specific Cytotoxicity T Lymphocytes Activated by Dendritic Cells Loaded with Apoptotic Tumor Cells

The Anti-Tumor Activity of Dendritic Cell/cytotoxic T Lymphocyte Induced by Cholangiocarcinoma-Derived Exosome and Its Ultrafiltered Lysate

In Vivo and in Vitro Activation of CTL by Murine Dendritic Cells Pulsed with Acid Eluted Tumor Antigen Peptides

Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.

Synergistic Anti-Gastric Cancer Effect and Mechanism of Newcastle Disease Virus in Combination with Gastric Cancer Antigen Loaded Dendritic Cells.

Disappearance of Bone Metastases in Chemotherapy-Resistant Gastric Cancer Treated with Antigen Peptide-Pulsed Dendritic Cell-Activated Cytotoxic T Lymphocyte Immunotherapy: A Case Report

Anti-colonic Cancer Effect in Vitro of MUC1 Specific CTLs Induced by MUC1 Core Peptide Tandem Repeats Gene-Modified Dendritic Cells Via Lentiviral Transduction

Dendritic Cells Loaded with Ultrasound-Ablated Tumour Induce in Vivo Specific Antitumour Immune Responses

Cytotoxicity of specific CTL induced by EBV-LMP2A peptide on human EBV associated gastric carcinoma cell in vitro

Dendritic cells with synergistte activation of Toll-like receptor ligands induce antitumor effects against colon cancer in vitro

Enhanced Antitumor Effects of Tumor Antigen-Pulsed Dendritic Cells by Their Transfection with GM-CSF Gene.

Cytotoxic Effect of TGF-β Insensitive Dendritic Cell Vaccine on Cytotoxic T Lymphocytes in Mice with Renal Cell Carcinoma

A fight for life Honoring Ralph Steinman′s memory through a preliminary study of in vitro and in vivo anti-tumor effects of BCG-activated dendritic cells

[Autologous lung cancer tissues derived gp96-peptide complex/dendritic cell vaccine induces the cytotoxic T cell response in vitro].

High Potency and Specific Anti-Tumor Immunoreaction Induced by Dendritic Cells and Superantigen

Dendritic Cells Vaccines Activated by Combined Toll-like Receptor Llgands Inhibit Murine Colon Cancer in Vivo

Synergistical Toll-Like Receptors Activated Dendritic Cells Induce Antitumor Effects Against Carcinoembryonic Antigen-Expressing Colon Cancer

[The Killing Effect of Cytotoxic T Lymphocytes on Esophageal Adenocarcinoma Cells Mediated by Gp96-Peptide Complexes].